 Palatin Technologies Inc NYSE: PTN filed an international patent application under the Patent Cooperation Treaty PCT related to the composition of PL9643 and a related family of melanocortin agonist peptides. The application establishes the base for the presumptive patent term, and if a patent is granted, it could provide patent protection out to 2041. 